The safety and tolerability of vortioxetine: analysis of data from randomised placebo-controlled trials and open-label extension studies
The safety and tolerability of vortioxetine in adults with major depressive disorder (MDD) was assessed. Tolerability was based on the nature, incidence and severity of treatment-emergent adverse events (TEAEs) during acute (6/8) week treatment in 11 randomised, double-blind placebo-controlled short...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
2016-02-23.
|
| Subjects: | |
| Online Access: | Get fulltext Get fulltext |